Search results
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 2 weeks agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 7 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
VYNE Therapeutics receives FDA approval for trial of VYN202
Clinical Trials Arena via Yahoo Finance· 2 days agoIf the Phase Ia segment is successful, VYNE will advance the drug to Phase Ib trials in individuals...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 6 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 1 day agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 1 week agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent of people with ...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 7 days agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...
Molly Murray: Why don't we know more about autoimmune diseases? (Opinion)
The Charleston Gazette· 1 week agoImagine feeling unwell for months, years — even decades — and never knowing why. Imagine the anguish of not understanding the suffering taking place in your body and the frustration of it not ...
Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)
ETF DAILY NEWS· 2 days agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 2 weeks agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...